Synthesis and antimicrobial activity of some new 4H-pyrrolo[1,2-a]benzimidazoles

Abstract

Some new 4H-pyrrolo[1,2-a]benzimidazoles(2a–2f) have been synthesized. The structures of these compounds were confirmed by IR, ¹H NMR, mass spectroscopy and elemental analysis. Compound 2a was further confirmed by X-ray diffraction. The in vitro antimicrobial activities of these compounds were determined against some gram-positive bacteria, gram-negative bacteria and fungi and their drug-resistant isolates in comparison with standard drugs. Antimicrobial results indicate that compounds 2c, 2d and 2e show moderately active antibacterial properties, their minimum inhibitory concentrations are from 12.5 μg/mL to 125 μg/mL. In the series, the most active compound against C. albicans is compound 2f with an MIC value of 31.25 μg/mL.

Keywords

4H-Pyrrolo[1,2-a]benzimidazole / Anti-bacterial / Anti-fungal

References

[1] Zhou Y, Wang D M, Zhao X G, Zhou H W, Chen C H, Dang G D. Chem. J. Chinese Universities, 2013, 34(10): 2427.

[2] Ruiz V R, Avelino C, Sabater M J. Tetrahedron, 2010, 66(3): 730.

[3] Kumar D, Jacob M R, Reynoldsa M B, Kerwin S M. Bioorg. Med. Chem., 2002, 10(12): 3997.

[4] Demirayak S, Kayagil I, Yurttaset L. Eur. J. Med. Chem., 2011, 46(1): 411.

[5] Refaat M H. Eur. J. Med. Chem., 2010, 45(7): 2949.

[6] Hranjec M, Kralj M, Piantanida I, Sedic M, Sÿuman L D, Karminski-Zamola G. J. Med. Chem., 2007, 50(23): 5696.

[7] Piskin A K, Ates-Alagoz Z. Turk. J. Biochem., 2009, 34: 39.

[8] Zhou R, Skibo E B. J. Med. Chem., 1996, 39(21): 4321.

[9] Craigo W A, le Sueur B W, Skibo E B. J. Med. Chem., 1999, 42(17): 3324.

[10] Suleman A, Skibo E B. J. Med. Chem., 2002, 45(6): 1211.

[11] Xing C G, Wu P, Skibo E B. J. Med. Chem., 2000, 43(3): 457.

[12] Schulz W G, Islam I, Skibo E B. J. Med. Chem., 1995, 38(1): 109.

[13] Nehal M, Elwan N M. Tetrahedron, 2004, 60(5): 1161.

[14] Awadallah M, Seppeltb A, Shorafa K H. Tetrahedron, 2006, 62(33): 7744.

[15] Despina A, Carnpi M E, Fallon G D. Aust. J. Chem., 1993, 46: 1623.

[16] Ogura H, Kikuchi K. J. Org. Chem., 1972, 37(17): 2679.

[17] Matsuda Y. Heterocycle, 1992, 33: 295.

[18] Watanabe H, Tsuge O. J. Org. Chem., 1989, 54(2): 420.

[19] Wang B X, Hu J X, Zhang X C, Hu H W. J. Heterocycl. Chem., 2000, 37(6): 1533.

[20] Shen Z Y, Han Q R, Wang B X, Shen J. J. Function. Mater., 2008, 4: 536.

[21] Wei X, Hu Y, Li T. J. Chem. Soc., Perkin Trans I., 1993, 2487.

[22] Wang B X, Li J, Jiang X, Hu H W. J. Chem. Soc., Perkin Trans I., 1999, 1571.

[23] Rohini R, Reddy P M, Shanker K, Huc A, Ravinder V. Eur. J. Med. Chem., 2010, 45(3): 1200.

[24] Reddy P M, Ho Y P, Shanker K, Rohini R, Ravinder V. Eur. J. Med. Chem., 2009, 44(6): 2621.

[25] Andrews J. Antimicrob Agents Chem., 2010, 54: 5.

[26] Oludotun A P, Edet E U, Santhosh M S. Eur. J. Med. Chem., 2008, 43(5): 1095.

[27] Kotretsou S, Mingeot-Leclercq M P, Constantinou-Kokotou V, Brasseur R, Georgiadis M P, Tulkens P M. J. Med. Chem., 1995, 38(23): 4710.

[28] Chaudhari B R, Rindhe S S. J. Serb. Chem. Soc., 2010, 76: 1199.

[29] Al-Tel T H, Al-Qawasmeh R A, Zaarour R. Eur. J. Med. Chem., 2011, 46(5): 1874.

[30] Ansari K F, Lal C. Eur. J. Med. Chem., 2009, 44(10): 4028.

[31] Ansari K F, Lal C. Eur. J. Med. Chem., 2009, 44(5): 2294.

[32] Alper-Hayta S, Arisoy M, Temiz-Arpaci, Kaynak F. Eur. J. Med. Chem., 2008, 43(11): 2568.

[33] Ghali R M, Hashim R, Alshahateet S F, Mehdi S H, Sulaiman O, Murugaiyah V, Aruldass C A. J. Mole. Struct., 2011, 1005(1): 152.